stella
beta
PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer — Stella
Recruiting
Back to Cervical Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
United States
University of Arkansas for Medical Sciences, Little Rock, Arkansas
National Institute of Health, Bethesda, Maryland
University of Washington, Seattle, Washington
View full record on ClinicalTrials.gov